Fuhlendorff J, Gether U, Aakerlund L, Langeland-Johansen N, Thøgersen H, Melberg S G, Olsen U B, Thastrup O, Schwartz T W
University Department of Clinical Chemistry, Rigshospitalet, Copenhagen, Denmark.
Proc Natl Acad Sci U S A. 1990 Jan;87(1):182-6. doi: 10.1073/pnas.87.1.182.
Two types of binding sites have previously been described for 36-amino acid neuropeptide Y (NPY), called Y1 and Y2 receptors. Y2 receptors can bind long C-terminal fragments of NPY-e.g., NPY-(13-36)-peptide. In contrast, Y1 receptors have until now only been characterized as NPY receptors that do not bind such fragments. In the present study an NPY analog is presented, [Leu31, Pro34]NPY, which in a series of human neuroblastoma cell lines and on rat PC-12 cells can displace radiolabeled NPY only from cells that express Y1 receptors and not from those expressing Y2 receptors. The radiolabeled analog, [125I-Tyr36] monoiodo-[Leu31, Pro34]NPY, also binds specifically only to cells with Y1 receptors. The binding of this analog to Y1 receptors on human neuroblastoma cells is associated with a transient increase in cytoplasmic free calcium concentrations similar to the response observed with NPY. [Leu31, Pro34]NPY is also active in vivo as it is even more potent than NPY in increasing blood pressure in anesthetized rats. It is concluded that [Leu31, Pro34]NPY is a specific Y1 receptor agonist and that the analog or variants of it can be useful in delineating the physiological importance of Y1 receptors.
先前已描述了36个氨基酸的神经肽Y(NPY)的两种结合位点,分别称为Y1和Y2受体。Y2受体可结合NPY的长C末端片段,例如NPY-(13-36)肽。相比之下,Y1受体到目前为止仅被表征为不结合此类片段的NPY受体。在本研究中,提出了一种NPY类似物,即[Leu31, Pro34]NPY,在一系列人神经母细胞瘤细胞系和大鼠PC-12细胞上,它只能从表达Y1受体的细胞中取代放射性标记的NPY,而不能从表达Y2受体的细胞中取代。放射性标记的类似物[125I-Tyr36]单碘-[Leu31, Pro34]NPY也仅特异性结合具有Y1受体的细胞。这种类似物与人神经母细胞瘤细胞上Y1受体的结合与细胞质游离钙浓度的短暂升高有关,类似于用NPY观察到的反应。[Leu31, Pro34]NPY在体内也有活性,因为它在麻醉大鼠中升高血压的作用甚至比NPY更强。得出的结论是,[Leu31, Pro34]NPY是一种特异性Y1受体激动剂,其类似物或变体可用于阐明Y1受体的生理重要性。